Effects of atomoxetine on cognitive functions in normal subjects using fMRI
Not Applicable
Suspended
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000012947
- Lead Sponsor
- ippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects with drug allergy. Subjects with cardiovascular disorder, glaucoma, liver and renal dysfunction, urination difficulty. Subjects with history of pheochromocytoma, convulsive seizure, hypertension, cerebrovascular disorder, orthostatic hypotension. Subjects taking any drug within 1 week. Subjects with contraindications to MRI. Subjects who are judged as not suitable for participation in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of BOLD signal changes measured by fMRI between placebo and atomoxetine conditions.
- Secondary Outcome Measures
Name Time Method